Private vaccinations
HPV (Gardasil 9)
Nine-valent HPV vaccine protecting against the HPV types responsible for the majority of cervical, anal, oropharyngeal and other cancers, plus genital warts.
About this vaccine
About HPV (Gardasil 9)
Gardasil 9 protects against nine strains of human papillomavirus: seven high-risk oncogenic types (16, 18, 31, 33, 45, 52, 58) responsible for the majority of HPV-related cancers, plus types 6 and 11 which cause the majority of genital warts.
In the UK, HPV vaccination is offered routinely to boys and girls aged 12–13 on the NHS. Catch-up vaccination is available privately, and Gardasil 9 is licensed up to age 45.
What it protects against
Protection
Cervical, vulvar, vaginal, anal and oropharyngeal cancers linked to HPV, high-grade precancerous cervical lesions (CIN2+), and genital warts. Vaccination is most effective when given before exposure to HPV, but still offers benefit after the onset of sexual activity.
How it's delivered
Delivery
Intramuscular injection into the upper arm.
Doses
Number of doses required
Two doses (0 and 6–12 months) for those starting the course between 9 and 14 years. Three doses (0, 2 and 6 months) for those starting from 15 years and older, and for immunocompromised patients.
Who should have it
Who should consider it
Girls and boys, men and women up to age 45. Particularly encouraged for anyone who missed the school programme.
Contraindications
Important information
Confirmed anaphylactic reaction to a previous dose or to any component of the vaccine. Not recommended during pregnancy — postpone until after delivery.
Vaccination enquiry